Identification of functional SNPs in BARD1 gene and in silico analysis of damaging SNPs: based on data procured from

Ali A Alshatwi1, Tarique N Hasan, Naveed A Syed

  • 1Molecular Cancer Biology Research Laboratory, Department of Food Science and Nutrition, King Saud University, Riyadh, Saudi Arabia. alialshatwi@gmail.com

Plos One
|October 12, 2012
PubMed
Abstract

Insights

This study identified four deleterious single nucleotide polymorphisms (SNPs) in the BARD1 gene, rs4986841, rs111367604, rs13389423, and rs139785364, which reduce protein stability and are promising for future female cancer research.

Area of Science:

  • Genetics
  • Bioinformatics
  • Cancer Research

Background:

  • The BARD1 gene is crucial for the BRCA1-associated RING domain protein.
  • Mutations in BARD1 are linked to sporadic breast, ovarian, and uterine cancers.
  • Single nucleotide polymorphisms (SNPs) in BARD1 may influence female cancer development.

Purpose of the Study:

  • To identify functional non-synonymous SNPs (nsSNPs) in the BARD1 gene.
  • To analyze the potential impact of these nsSNPs on BARD1 protein function and stability.
  • To provide data for larger population-based studies on female cancers.

Main Methods:

  • Utilized the dbSNP database for SNP identification.
  • Employed bioinformatics tools including SIFT, PolyPhen, FastSNP, PDBSum, I-Mutant, and ExPASy-PROSIT.
  • Analyzed SNPs in coding and non-coding regions (5' UTR, 3' UTR, intronic).

Main Results:

  • Identified 50 nsSNPs in BARD1, with 11 predicted as not tolerable and 27 as damaging by SIFT and PolyPhen.
  • rs58253676 (3' UTR) may affect splicing; rs17489363 and rs17426219 (5' UTR) may alter transcriptional binding.
  • Four nsSNPs (rs4986841, rs111367604, rs13389423, rs139785364) were identified as deleterious, decreasing BARD1 protein stability.

Conclusions:

  • Four specific nsSNPs in BARD1 (rs4986841, rs111367604, rs13389423, rs139785364) are predicted to be deleterious and reduce protein stability.
  • These identified nsSNPs are valuable candidates for future large-scale population studies on female cancers.
  • Bioinformatic analysis provides a robust method for prioritizing functional SNPs in cancer-related genes.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are: